A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Moxidectin (Primary)
- Indications Onchocerciasis
- Focus Therapeutic Use
- Sponsors Medicines Development Limited
- 20 Jul 2017 Status changed from active, no longer recruiting to completed.
- 26 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Jan 2017 Status changed from not yet recruiting to recruiting.